Ameren CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
AEE
Ameren CORPVanguard Capital Management has disclosed beneficial ownership of 7.53% of Ameren Corp's common stock as of March 31, 2026.
NYSE
AEE
Ameren CORPVanguard Portfolio Management has reported a beneficial ownership of 5.74% in Ameren Corp's common stock as of March 31, 2026.
NYSE
AEE
Ameren CORPThe Vanguard Group has amended its Schedule 13G filing for Ameren Corp, reporting zero beneficial ownership following an internal realignment that disaggregated its reporting.
NYSE
AEE
Ameren CORPT. Rowe Price Associates, Inc. has reported an 8.1% beneficial ownership stake in Ameren Corporation, holding over 21 million shares as of December 31, 2025.
NYSE
AEE
Ameren CORPSCHEDULE 13G/A: BlackRock Boosts Ameren Stake to 8.1%
BlackRock, Inc. has reported an 8.1% beneficial ownership stake in Ameren Corporation's common stock, holding over 21.8 million shares.
NYSE
AEE
Ameren CORPState Street Corporation has reported a 5.2% beneficial ownership stake in Ameren Corp's common stock, holding over 14 million shares.
NYSE
AEE
Ameren CORPSCHEDULE 13G: T. Rowe Price Discloses 5.2% Stake in Ameren Corp
T. Rowe Price Investment Management, Inc. has reported a 5.2% beneficial ownership stake in Ameren Corporation's common stock as of June 30, 2025.
NYSE
AEE
Ameren CORPT. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 4.8% in Ameren Corporation's common stock as of March 31, 2025.